| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |